Valeant Ex-CFO Schiller Named Interim CEO With Pearson IllBy and
Ingram to become interim chairman during chief's medical leave
Naming single CEO said to clarify management structure
Valeant Pharmaceuticals International Inc. named Howard Schiller to run the company as interim chief executive officer, tapping a board member and former top executive to help restore the company’s image while Michael Pearson remains hospitalized with severe pneumonia.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.